Elsevier

Life Sciences

Volume 30, Issue 17, 26 April 1982, Pages 1427-1434
Life Sciences

Possible role of octopamine and tyramine in the antihypertensive and antidepressant effects of tyrosine

https://doi.org/10.1016/0024-3205(82)90556-2Get rights and content

Abstract

The administration of a dose of 200 mg/kg of tyrosine (as either the free amino acid or the ethyl ester) increased the 24-hour excretion of p-hydroxyphenethyleneglycol (p-HPG) and p-hydroxyphenylethanol, metabolites of octopamine and tyramine, by 147 and 50%, respectively. One hour after this dose of tyrosine, brain levels of p-HPG and p-hydroxyphenylacetic acid (p-HPA), another metabolite of tyramine, were increased by 82 and 196%, respectively. Pretreatment with Ro4-4602, a peripheral decarboxylase inhibitor, reduced by 50% the tyrosine-induced increases in brain p-HPA levels, suggesting that tyramine was partially formed in the brain parenchyma. Tyrosine caused only slight, but non- significant increases in brain levels of catecholamine metabolites. These results suggest that tyrosine-induced increases in the production of tyramine and octopamine in brain may account for some of the effects of tyrosine, such as its antihypertensive and reported antidepressant properties.

References (30)

  • Y. Yamori et al.

    Eur. J. Pharmacol.

    (1980)
  • I.K. Goldberg

    Lancet

    (1980)
  • D.J. Edwards et al.

    Biochem. Med.

    (1981)
  • D.J. Edwards et al.

    Prog. Neuro-Psychopharmacol.

    (1981)
  • A.F. Sved et al.

    Life Sci.

    (1981)
  • S.H. Buck et al.

    Brain Res.

    (1977)
  • A.F. Sved et al.
  • J.L. Meek et al.

    J. Pharmacol. Exp. Ther.

    (1973)
  • M.R. Bresnahan et al.

    Am. J. Physiol.

    (1980)
  • L.A. Conlay et al.

    Science

    (1981)
  • N.A. Scott et al.

    Science

    (1981)
  • A.J. Gelenberg et al.

    Am. J. Psychiat.

    (1980)
  • B. Shalita et al.

    Experientia

    (1977)
  • D.J. Edwards et al.

    J. Neurochem.

    (1981)
  • F.A.J. Muskiet et al.

    J. Labeled Compounds Radiopharmaceuticals

    (1978)
  • Cited by (28)

    • Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K

      2020, Neurochemistry International
      Citation Excerpt :

      The intraneuronal concentration of free tyrosine is one factor that can influence the synthesis of catecholamine neurotransmitters and trace amines (Wurtman et al., 1974; Gibson and Wurtman, 1978; Edwards, 1982).

    • Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress

      2016, Ageing Research Reviews
      Citation Excerpt :

      Additionally, when 5 mg/kg m-tyrosine was administered to humans, the major metabolite was m-hydroxyphenylacetic acid, which was believed to follow decarboxylation of m-tyrosine to m-tyramine (Fell et al., 1979). The detection of tyramine and its metabolites were also detected after either tyrosine isomer was administered to various animal models including cats and rats (Edwards, 1982; Edwards and Rizk, 1981; Gibson and Wurtman, 1978; McQuade and Juorio, 1983; Mitoma et al., 1957; Pogrund et al., 1961). Whether decarboxylation of m- and o-tyrosine to their respective isomers of tyramine is sufficient to prevent toxicity has yet to be tested.

    • A radioenzymatic assay for para-tyramine and para-octopamine

      1988, Biochemical Medicine and Metabolic Biology
    View all citing articles on Scopus
    View full text